Calcium and supplement D supplements usually do not reduce breast cancer A big multicenter randomized clinical trial reported that supplementation with calcium and vitamin D didn’t reduce breast cancer risk in the overall population femmes préménopausées . However, exploratory analyses recommend the effect of supplement D and supplements on breast malignancy risk may vary according to a woman’s initial supplement use. ‘Our findings claim that calcium and supplement D supplementation may reduce breasts cancer risk in some women, but more study is required to clarify these results,’ said Rowan T. Chlebowski, MD, PhD, Medical Oncologist at the LA Biomedical Study Institute at Harbor-UCLA Medical Center and the study’s lead author.
Despite a lot more than 30 years of medical trials, uncertainty has existed regarding the optimal use of antihypertensive drugs in sufferers with coronary artery disease , according to history information in the article. Steven E. Nissen, M.D., of the Cleveland Clinic Lerner College of Medication, Cleveland, and co-workers examined the effects of antihypertensive medicines in 1,991 sufferers with CAD and normal blood circulation pressure in the Assessment of Amlodipine vs. Enalapril to Limit Occurrences of Thrombosis study, a double-blind, randomized, multicenter 24-month trial . Patients received either the calcium channel blocker amlodipine ; the angiotensin-switching enzyme inhibitor enalapril ; or placebo. Furthermore, a subset of 274 patients underwent serial intravascular ultrasound examinations to determine if either or both medicines reduced the progression of atherosclerosis.